Cargando…
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
BACKGROUND: Interstitial lung disease is a major cause of morbidity and mortality in systemic sclerosis (SSc), with insufficiently effective treatment options. Progression of pulmonary fibrosis involves expanding populations of fibroblasts, and the accumulation of extracellular matrix proteins. Char...
Autores principales: | Lindahl, Gisela E, Stock, Carmel JW, Shi-Wen, Xu, Leoni, Patricia, Sestini, Piersante, Howat, Sarah L, Bou-Gharios, George, Nicholson, Andrew G, Denton, Christopher P, Grutters, Jan C, Maher, Toby M, Wells, Athol U, Abraham, David J, Renzoni, Elisabetta A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750263/ https://www.ncbi.nlm.nih.gov/pubmed/23915349 http://dx.doi.org/10.1186/1465-9921-14-80 |
Ejemplares similares
-
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020) -
Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
por: Rossi, Antonella, et al.
Publicado: (2010) -
Gene expression profiling reveals novel TGFβ targets in adult lung fibroblasts
por: Renzoni, Elisabetta A, et al.
Publicado: (2004) -
Interstitial pneumonia with autoimmune features: challenges and controversies
por: Mackintosh, John A., et al.
Publicado: (2021) -
Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation
por: Stock, Carmel J. W., et al.
Publicado: (2019)